ProPharma has the bespoke solutions to your business’s complex challenges.
We partner with pharmaceutical, biotechnology, and medical device clients to inspire the future of science to deliver the technologies, medicines, and therapies to improve patient health and safety.
Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.
Partner with us!
Global Footprint
North America
United Kingdom
Europe
Asia Pacific
Washington, DC
1129 20th St NW, Suite 600
Washington, DC 20036
1-202-833-8077
Hyderabad
3rd Block, 7th Floor,
My Home Hub, Madhapur, Patrika Nagar, HITEC City,
Hyderabad, Telangana 500081
Global Footprint
US and Canada
Raleigh (HQ)
107 West Hargett St.
Raleigh, NC 27601
Bozeman
274 Discovery Dr, Suite 100 Bozeman, MT 59718
Chicago (Deerfield)
10 Parkway North, Suite 310
Deerfield, IL 60015
Chicago (Loop)
200 N. Lasalle Street, Suite 2400
Chicago, IL 60601
Chicago (Western Springs)
800 Hillgrove Avenue, Suite 201 Western Springs, IL 60558
Cleveland
24651 Center Ridge Rd, Suite 475, Westlake, OH 44145
Philadelphia
501 W. Office Center Dr, Suite 350
Fort Washington, PA 19034
San Diego
10590 West Ocean Air Drive, Suite 220
San Diego, CA 92130
Washington, DC
1129 20th St NW, Suite 600
Washington, DC 20036
1-202-833-8077
Windsor
3000 Temple Dr, Suite 200
Windsor, ON N8W 5J6
UK
Birmingham
Unit 2.03, ICENTRUM
Holt Street
Birmingham B7 4BP
London
John Stow House 18
Bevis Mark
London EC3A 7JB
North Yorkshire
Olliver, Aske, Richmond
North Yorkshire, DL10 5HX
Europe
Berlin
Siemensdamm 62
13627 Berlin
Leiden
Schipholweg 73 – 75
2316 ZL Leiden
Lund
Medicon Village
223 81 LUND
Stockholm
Fleminggatan 18
SE -112 26 Stockholm
Asia Pacific
Melbourne (Hawthorn)
Unit 5, Level 2, 40 Burwood Rd
Hawthorn VIC 3122
Hyderabad
3rd Block, 7th Floor,
My Home Hub, Madhapur, Patrika Nagar, HITEC City,
Hyderabad, Telangana 500081
Tokyo
5-27-5 Sendagaya, Shibuya-ku (suite 13-101, 13-102, 13-113, 13-130)
Client Feedback
“Working with ProPharma has been a pleasure. The auditors are friendly, knowledgeable, and communicative. They have been a great resource to help us complete a wide range of audits and manage our supplier quality.”
Emily King - Azurity Pharmaceuticals
"Working with the whole team at ProPharma has been an honor. For several years they have acted on our behalf as a trusted customer facing vendor for medical information inquiries. their subject matter expertise, collaborative nature and high level of professionalism have been a bellwether for us through all stages of marketing and scaling a new drug product. The next time my team is in need of scientific communication outsourcing, PPG will be my first stop."
Jenny Strauss - Biohaven Pharmaceuticals
Manager, Medical Information and Communications
“Lyell engaged ProPharma as our validation partner as we built and qualified the LyFE Manufacturing Center. ProPharma assisted in all phases of the qualification including establishing the facility and equipment qualification program, protocol generation, protocol execution, and writing the final reports. They played a critical role in getting the facility ready on time and on budget to support the Lyell clinical trials.”
David Shank - Lyell Immunopharma, Inc.
Vice President, Manufacturing
"ProPharma has been a valued and trusted partner as our Medical Information third party call center for a number of years. During that time they have exhibited the highest level of quality, compliance, and professionalism. Always keeping the needs of our mutual customers front and center. The team is diverse in their staff and their offered services, which enables us to customize support to business need. We would highly recommend the services of ProPharma without hesitation.”
Laurie Wingett - Bayer, Inc.
Medical Affairs Head, Primary Care (WH/established brands) and Medical Operations
When we partnered with Oxford University to enable global development, manufacturing and distribution of our vaccine, we put broad and equitable access at the heart of our response. The result was a vaccine that was developed in under a year, and we believe we have made a significant impact in terms of global public health. Based on data published in The Lancet and an analysis by Airfinity, our vaccine is estimated to have saved over 6 million lives in the first year of vaccination.
AstraZeneca supplied the vaccine with no profit during the pandemic and we are supplying the vaccine with no profit in low-income countries today. To date, over 3 billion doses have been released for supply to more than 180 countries. AstraZeneca was the first and largest contributor in 2020 and 2021 to COVAX, with over 470 million doses. Doses that couldn’t have been released without the partnership with ProPharma. In our collaboration an estimated 500 million doses underwent thorough quality assessment to provide a vaccine made for the world.
Pythia Segers - Astra Zeneca
"We have had the pleasure of working with ProPharma on a global scale for several years assisting us with Medical Information Call Center and writing workflows. Their ability to adapt based on the client’s needs is very commendable. Also, we are fortunate to work with a very talented team of professionals who are always eager to work with us and deliver quality service to our customers. "
Anonymous